A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1969
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus ; day:21 ; month:11 ; year:2016 ; pages:1-10
Drugs & aging ; (21.11.2016), 1-10
- Creator
-
Heise, Tim
- Contributor
-
Hövelmann, Ulrike
Zijlstra, Eric
Stender-Petersen, Kirstine
Jacobsen, Jacob Bonde
Haahr, Hanne
SpringerLink (Online service)
- DOI
-
10.1007/s40266-016-0418-6
- URN
-
urn:nbn:de:1111-201612113860
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heise, Tim
- Hövelmann, Ulrike
- Zijlstra, Eric
- Stender-Petersen, Kirstine
- Jacobsen, Jacob Bonde
- Haahr, Hanne
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences
A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use
Pharmacokinetic–pharmacodynamic modelling of the hypoglycaemic effect of pulsatile administration of human insulin in rats
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences
A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use
Pharmacokinetic–pharmacodynamic modelling of the hypoglycaemic effect of pulsatile administration of human insulin in rats
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences
A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use
Pharmacokinetic–pharmacodynamic modelling of the hypoglycaemic effect of pulsatile administration of human insulin in rats
Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat